Endocrinology, Diabetes & Metabolism Doctors in Indianapolis, IN Accepting Medicare

47 Endocrinology, Diabetes & Metabolism doctors found. Showing 41 - 47

Dr. Clare Jung Eun Lee, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 720 Eskenazi Ave, Indianapolis, IN 46202 Phone: 317-880-5475

Richard Clark Perry, DO Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 8205 E 56th Street, Suite 100, Indianapolis, IN 46216 Phone: 317-621-4044    Fax: 317-621-4050

Bradley S Guill, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 8205 E 56th St, Suite 100, Indianapolis, IN 46216 Phone: 317-621-4044    Fax: 317-621-4050

Ashley Marie Jancuska, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 8435 Clearvista Pl Ste 101, Indianapolis, IN 46256 Phone: 317-621-1006

Michael J Waddell, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 5230 E Stop 11 Rd Ste 150, Indianapolis, IN 46237 Phone: 317-865-5904    Fax: 317-865-5321

Melvin Jay Prince, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: Gennesaret Free Clinic 615 N Alabama St, Suite 136, Indianapolis, IN 46204 Phone: 317-639-5645

Dr. Janet Tobian, M.D., PH.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 9121 Walnut Grove Dr, Indianapolis, IN 46236 Phone: 317-826-7515    Fax: 317-826-7516

News Archive

Case Fatality Rate alone may be a misleading measure of overall COVID-19 mortality

The COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected over 16.67 million individuals and caused over 659,000 deaths around the world. Commonly the deadly virus and its impact are measured by the case fatality ratio (CFR).

Halozyme commences HTI-501 clinical trial for cellulite in women

Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the diabetes, cancer, dermatology and drug delivery markets, today announced the commencement of a Phase 1/2 clinical trial with HTI-501 (rHuCAT-L) in women with moderate to severe edematous fibrosclerotic panniculopathy (also known as cellulite).

Clinical trials in Australia take too long– need uniform standards: Report

A government report says that clinical trials for new medicines are taking too long and should be sped up so patients can access urgently needed treatment. The states and territories have been urged to adopt uniform rules on approving trials so the scientific experiments can be conducted more efficiently and effectively.

Topical NSAIDs are safe and effective for acute pain: Researchers

Gels, creams and sprays containing painkillers such as ibuprofen, diclofenac, ketoprofen, and piroxicam are safe and effective treatments for local pain, according to Cochrane Researchers. A new systematic review they have conducted shows that topical non-steroidal anti-inflammatory drugs are more effective than placebos for treating short-term pain and have few side effects.

Read more Medical News

› Verified 4 days ago

• 1
• 2
• 3(current)